Skip to content
buyWeak cluster of 2

Christina Rizopoulos Valauri bought $18k of VBIO

director at Valion Bio, Inc.. 19,000 shares at an average of $0.95, traded Apr 1, 2026, filed Apr 2, 2026.

Conviction score
31
Value
$18k
19,000 shares
Holdings after
19,000
change unknown
From 52-week low
-
no price yet
From 52-week high
-
no price yet

Score components

  • Role
    Director
    +15
  • Trade size
    $18k at market
    0
  • Relative to holdings
    First purchase: no shares before this trade
    +8
  • Price context
    No price history yet
    0
  • Cluster
    2 insiders buying within 14 days
    +8
  • Repeat buying
    First buy in 90 days
    0
  • Track record
    Too few past buys to judge (0 with prices)
    0

What happened after comparable buys

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Rows in this filing

Every transaction in Form 4 0001683168-26-002599, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Apr 1, 2026POpen-market purchase
Common Stock
+19,000$0.95$18k19,000Apr 2, 2026

Related signals

Other insiders at Valion Bio, Inc. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
31Weak
VBIObuy 2
Valion Bio, Inc.
Sheryle Bolton
director
$10k
10,000 shares
-

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.